Clinical Trial: Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White

Brief Summary: The purpose of this study is to evaluate the efficacy of PDE-3 inhibitor, cilostazol, in prevention and treatment of vascular dementia, in those with brain white matter lesions and vascular risk factors.

Detailed Summary:
Sponsor: Peking University First Hospital

Current Primary Outcome: changes of the scores of MMSE, MOCA,CDR,and Blessed-Roth [ Time Frame: one year ]

Original Primary Outcome: Same as current

Current Secondary Outcome: stroke recurrence, other vascular ischemic events, bleeding events [ Time Frame: one year ]

Original Secondary Outcome: Same as current

Information By: Peking University First Hospital

Dates:
Date Received: February 17, 2009
Date Started: March 2008
Date Completion:
Last Updated: May 5, 2015
Last Verified: December 2009